25 results for “nafld”. Showing 25 of 39,449.
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population.
NAFLD into three distinct molecular subtypes (NAFLD-mSI, NAFLD-mSII
Integrative analysis identifies oxidative stress biomarkers in non-alcoholic fatty liver disease via machine learning and weighted gene co-expression network analysis.
NAFLD-related genes, and genes closely associated with NAFLD as identified
Peripheral amyloid-β clearance mediates cognitive impairment in non-alcoholic fatty liver disease.
NAFLD) is a prevalent risk factor for cognitive impairment. Cerebral
SIRT1: Harnessing multiple pathways to hinder NAFLD.
NAFLD. SIRT1 activation or overexpression attenuate NAFLD, while SIRT1 deficiency
Inhibition of receptor-interacting protein kinase 1 improves experimental non-alcoholic fatty liver disease.
NAFLD), hepatocytes can undergo necroptosis: a regulated form of necrotic
Predictors of Non-Alcoholic Liver Disease in Ethnically Diverse Overweight Children and Adolescents.
NAFLD) and sleep, Physical Activity (PA), and screen-time habits/behaviors
Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
NAFLD) is sub-chronic liver inflammation that leads and contributes
Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease.
NAFLD across diverse ancestries. We identified NAFLD-associated variants at torsin
Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism.
NAFLD), characterized by hepatic steatosis, is a common metabolic liver
Hesperetin ameliorates hepatic oxidative stress and inflammation via the PI3K/AKT-Nrf2-ARE pathway in oleic acid-induced HepG2 cells and a rat model of high-fat diet-induced NAFLD.
NAFLD) is considered the most common liver disease. Dietary supplementation
S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis.
NAFLD. The expression of S100A11 in different models of NAFLD
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion.
NAFLD). Genetic modification has been employed to enhance the characteristics
Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study.
NAFLD). Based on bioinformatic tools. Subsequently, the details of the interaction
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆.
NAFLD. The GWAS involved 1,483 European NAFLD cases and 17,781 genetically
Trehalose Ameliorates Nonalcoholic Fatty Liver Disease by Regulating IRE1α-TFEB Signaling Pathway.
NAFLD), characterized by hepatic lipid deposition, is one of the most
Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model.
NAFLD using the free fatty acid (FFA)-induced NAFLD spheroid
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets.
NAFLD), currently the leading cause of global chronic liver disease
NUP85 alleviates lipid metabolism and inflammation by regulating PI3K/AKT signaling pathway in nonalcoholic fatty liver disease.
NAFLD) is one of the common causes of chronic liver
Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis.
NAFLD mouse model. RESULTS: Ketogenic function was decreased in NAFLD
Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.
NAFLD) secondary to high-fat diets together with free fatty
Ginsenosides Rc, as a novel SIRT6 activator, protects mice against high fat diet induced NAFLD.
NAFLD), while effective therapeutic approach remains inadequate. Ginsenosides Rc has been
Nuciferine Alleviates High-Fat Diet- and ApoE-/--Induced Hepatic Steatosis and Ferroptosis in NAFLD Mice via the PPARα Signaling Pathway.
NAFLD) causes significant global mortality and healthcare costs with no recommended
Cyanidin-3-O-glucoside improves non-alcoholic fatty liver disease by promoting PINK1-mediated mitophagy in mice.
NAFLD) and the underlying mechanism. Non-alcoholic fatty liver disease
Hepatic fat as clinical outcome and therapeutic target for nonalcoholic fatty liver disease.
NAFLD) is rapidly becoming the leading cause of advanced liver
A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures.
NAFLD) is a common, progressive liver disease strongly associated with